Successful Immune Checkpoint Inhibitor Rechallenge after Immune-Related Pericarditis: Clinical Case Series.

Adrian M. M. Chye,Ina I. C. Nordman,Aaron L. L. Sverdlov

Frontiers in cardiovascular medicine（2022）

引用 1|浏览3

暂无评分

摘要

Pericardial diseases secondary to immune checkpoint inhibitors (ICI) are rare. Here, we describe two cases of immune-related pericarditis caused by ICI for treatment of advanced NSCLC. Select patients can be successfully rechallenged with ICI after immune-related pericardial disease.

查看译文

关键词

immune checkpoint inhibitors,immune-related adverse events,cardiotoxicity,pericarditis,lung cancer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要